Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

DKB Fonds - Pharma Fonds

+ Add to Watchlist

DKBPHAR:LX

68.99 EUR 0.10 0.14%

As of 11:05:52 ET on 04/24/2015.

Snapshot for DKB Fonds - Pharma Fonds (DKBPHAR)

Year To Date: +22.45% 3-Month: +12.95% 3-Year: +31.54% 52-Week Range: 43.36 - 69.44
1-Month: +1.53% 1-Year: +57.69% 5-Year: +20.77% Beta vs MSGUHC: 0.88

Mutual Fund Chart for DKBPHAR

No chart data available.
  • DKBPHAR:LX 68.99
  • 1M
  • 1Y
Interactive DKBPHAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DKBPHAR

DKB Pharma Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term growth. The Fund invests in equities issued by pharmaceutical, technology and biotechnology companies in North America and Europe.

Inception Date: 11-22-1999 Telephone: 352-424345464
Managers: MARKUS HAMELLA
Web Site: www.bayerninvest.lu

Fundamentals for DKBPHAR

NAV (on 2015-04-24) 68.99
Assets (M) (on 2015-04-24) 49.98
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DKBPHAR

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for DKBPHAR

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.40
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.82

Top Fund Holdings for DKBPHAR

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 31,933 2,987,266 6.012%
Pfizer Inc 85,500 2,760,914 5.556%
Roche Holding AG 7,850 1,988,790 4.002%
Merck & Co Inc 34,000 1,830,055 3.683%
Sanofi 18,000 1,668,600 3.358%
Gilead Sciences Inc 17,100 1,588,551 3.197%
Amgen Inc 9,600 1,455,261 2.929%
UnitedHealth Group Inc 11,800 1,317,305 2.651%
GlaxoSmithKline PLC 57,000 1,232,460 2.480%
Medtronic PLC 16,797 1,215,283 2.446%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil